Skip to main content
. 2016 Sep 8;6:32548. doi: 10.1038/srep32548

Figure 3. Validation of plasma PLTP and MASP-1 levels in AMD patients and healthy controls (HCs) by ELISA.

Figure 3

Concentrations of (A) PLTP and (B) MASP-1 were measured in samples from HCs (n = 61) and early AMD (n = 41) and exudative AMD (n = 58) patients. (C) PLTP and (D) MASP-1 levels were validated in a second set of AMD patients and controls (n = 66).